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Abstract Background: Factors inﬂuencing patients’ motivations for enrolling in, and
their experiences of, orthopaedic randomized controlled trials (RCTs) are not fully
understood. Less is known about healthcare professionals’ (HCP) experiences of RCT
involvement.
Aim: This study investigates patients’ and HCPs’ views and experiences of RCT
participation and delivery to inform the planning of future RCTs.
Methods: Total hip or knee replacement patients (n = 24) participating in the single-
center double-blind APEX RCTs of an intra-operative anesthetic intervention and HCPs
(n = 15) involved in trial delivery were interviewed. Data were audio-recorded, tran-
scribed, anonymized and thematically analyzed.
Results: Although altruistic reasons for RCT participation were common, pa-
tients also weighed up demands of the RCT with the potential beneﬁts of taking part,
demonstrating the complex and conditional nature of trial participation. HCPs were
interested in RCT involvement as a means of contributing towards advances in medical
knowledge and also considered the costs and beneﬁts of RCT involvement.
* Corresponding author. School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol,
BS8 2PS, UK. Tel.: +44 117 9287323; fax: +44 117 92 87236.
E-mail address: j.horwood@bristol.ac.uk (J. Horwood).
International Journal of Orthopaedic and Trauma Nursing (2016) 20, 3–12
International
Journal of
Orthopaedic and
Trauma Nursing
www.elsevier.com/locate/ijotn
http://dx.doi.org/10.1016/j.ijotn.2015.05.002
1878-1241/Crown Copyright © 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Conclusion: Patients and HCPs value involvement in RCTs that they see as rel-
evant and of value, while imposing minimum burden. These ﬁndings have important
implications for the design of methods to recruit patients to RCTs and for planning
how an RCT might best interface with HCP clinical commitments.
Crown Copyright © 2015 Published by Elsevier Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Editor comments
Orthopaedic and trauma practitioners are increasingly involved in research studies. Sometimes they
are participants in the research process. They might also be research nurses who are involved in study
design, data collection and analysis. As previously discussed in this journal, research is everyone’s re-
sponsibility and practitioners will often simply meet patients in the course of their everyday work who
are participating in a research study and require nursing support. An understanding of how research
happens and the impact this has on participants is central to providing good care to patients who are
participants in studies. This paper provides some important information about the way patients feel
about their involvement. It also provides important insight into the research process and salient ethical
issues with particular reference to randomized controlled trials. This gives practitioners a practical
view of the conduct of research that can also help them to understand the process better.
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Introduction
Randomized controlled trials (RCTs) are internation-
ally recognized as the gold standard for evidence-
based medicine, important for determining the
effectiveness of medical interventions and direct-
ing medical practice (Brighton et al., 2003; Malavolta
et al., 2011). Limitations in the present orthopae-
dic evidence base include a scarcity of RCTs
(Chaudhry et al., 2008), relatively poor quality of or-
thopaedic RCTs and their reporting standards such
that they receive poor rating in meta-analyses
(Bhandari et al., 2003). This has led to a growing em-
phasis on the importance of providing orthopaedic
evidence through high quality RCTs (Chaudhry et al.,
2008; Swiontkowski and Agel, 2012; Tornetta et al.,
2012).
The success of RCTs relies on adequate and timely
recruitment. Recent reviews have concluded that re-
cruitment problems are evident in the majority of
RCTs (McDonald et al., 2006; Treweek et al., 2010).
Less than a third of RCTs achieve their recruitment
targets (Fletcher et al., 2012; McDonald et al., 2006),
which can undermine the power of an RCT, lead to
sampling bias and limit generalizability of results. Pa-
tients’ motivations for research participation are mul-
tifaceted and complex (Hallowell et al., 2010).
Common reasons include an altruistic belief that the
research will beneﬁt others and a view that a direct
beneﬁt will accrue from research participation
(McCann et al., 2010). While some patients de-
scribe participation based on one or other of these
reasons, the majority of patients report a mix of al-
truism and self-interest (Carroll et al., 2012; Locock
and Smith, 2011; McCann et al., 2010; Sikweyiya and
Jewkes, 2013). Potential RCT participants’ decision-
making involves weighing up perceived beneﬁts and
burden of RCT involvement to themselves, along-
side the potential wider social contribution of the
research (Cox and McGarry, 2003; McCann et al.,
2010). The complexity of the decision-making process
reveals why recruitment is an ongoing issue in RCTs
(McDonald et al., 2006; Treweek et al., 2010).
Retention of patients in RCTs is also of utmost im-
portance since the validity of RCT ﬁndings depends
on the completeness of follow-up data to ensure an
adequate pool of data is available to enable
robust analysis. Evidence suggests that effective
recruitment leads to the retention of patients
(Jerosch-Herold et al., 2011; Poston and Buescher,
2010). Unrealistic expectations of trial require-
ments, perceived beneﬁts or preference for treat-
ment arms can lead patients to drop out of studies
(Abraham et al., 2006; Paramasivan et al., 2011). It
is therefore vital, and an ethical obligation, that pa-
tients are fully informed of the requirements of RCT
participation and have realistic expectations about
possible beneﬁts and risks regardless of treatment
assignment (Mann et al., 2013), to be able to con-
sider trial participation fully and provide free and in-
formed consent (Donovan et al., 2009). Despite the
large number of orthopaedic patients entering RCTs,
there is a lack of research examining the factors that
inﬂuence orthopaedic patients’ motivations for, and
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experiences of, RCT participation. These can be in-
tegral to adequate trial recruitment (Sikweyiya and
Jewkes, 2013), leading to effective retention of par-
ticipants and completion of RCTs within the avail-
able time and resources (Jerosch-Herold et al., 2011;
Tramm et al., 2013).
Healthcare professionals’ (HCPs) engagement with
RCT processes is as important as that of patients and
can directly inﬂuence the quality of RCTs (Rendell
et al., 2007). By design, clinical RCTs are con-
ducted within busy clinical environments and often
rely on a range of HCPs to assist with RCT recruit-
ment, delivery, care of RCT patients and data col-
lection while continuing with existing clinical
commitments. The majority of research investigat-
ing the issues pertinent to HCPs’ involvement in RCTs
has focused on the effect of their views on recruit-
ment to studies (Ellis et al., 2001; Rendell et al.,
2007; Siminoff et al., 2000). There is also a paucity
of research that has examined the views and expe-
riences of HCPs involved in other aspects of RCT de-
livery. With a pressing need for more high quality
orthopaedic RCTs (Tornetta et al., 2012) it is im-
portant to understand the impact of conducting a
large scale RCT in an orthopaedic service.
Using qualitative methods, the present study
aimed to examine the views and experiences of HCPs
delivering orthopaedic RCTs and patients partici-
pating in the same RCTs. This aimed to enable the
identiﬁcation of factors that may enhance our un-
derstanding of how best to deliver successful ortho-
paedic RCTs and inform the design and delivery of
future RCTs.
Materials and methods
Study design
A qualitative in-depth interview study embedded
within the recent single center double-blind APEX
(Arthroplasty Pain Experience) RCTs was con-
ducted at a UK high volume orthopaedic center
(ISRCTN96095682) (Wylde et al., 2015). Qualitative
methods were chosen as the most appropriate means
to achieving a nuanced understanding of RCT in-
volvement (Locock and Smith, 2011; McCann et al.,
2010). The APEX trials were designed to evaluate the
effect of intra-operative local anesthetic wound in-
ﬁltration on the severity of joint pain at 12-months
after primary total knee replacement (TKR) or total
hip replacement (THR). Patients awaiting TKR or THR
were randomized to one of two groups: i) standard
anesthetic care; ii) intra-operative wound inﬁltra-
tion with a local anesthetic in addition to the stan-
dard anesthetic care. All patients were assessed
pre-operatively, daily during the hospital stay and
then at 3-months, 6-months and 12-months. Outcome
measures included self-report questionnaires, joint
examinations, analysis of x-rays, pressure algom-
etry and extraction of data from hospital records.
The primary outcome was the WOMAC pain subscale
(Bellamy et al., 1988) at 12-months. The RCTs suc-
cessfully recruited 316 TKR and 322 THR patients
between November 2009 and February 2012 (Wylde
et al., 2015). Four research nurses recruited pa-
tients and assisted with data collection while pa-
tients were in hospital. During the pilot stage of APEX
the recruitment nurses performed peer-review of re-
cruitment interviews to develop communication skills
required to convey RCT information to patients (Mann
et al., 2013).
Southampton and South West Hampshire NHS Re-
search Ethics Committee (B) (09/H0504/94) pro-
vided approval for the APEX trial and embedded
interview study.
Procedure
Patients listed for THR or TKR were sent APEX trial
information. Patients then attended pre-operative
assessment clinics before their surgery, were ap-
proached about participation in APEX by a research
nurse and were asked if they were willing to be con-
tacted about taking part in an interview. From those
who agreed to be contacted about the interview, a
purposive sample (in relation to age, gender and
balance of operated joint) was selected to gain a
diverse sample. HCPs were sampled to include those
involved in all stages of APEX: pre-assessment,
surgery and post-operative recovery.
All participants provided written, informed consent
prior to the in-depth interview. Flexible interview
topic guides were used to ensure primary issues were
covered during all interviews, but without dictat-
ing data collection. This allowed participants to in-
troduce unanticipated issues and in line with an
inductive approach these were revised in light of
emerging ﬁndings. Open-ended questioning tech-
niques were used to elicit participants’ experi-
ences and views of key events of joint replacement
and trial participation. Patients’ accounts of their
experiences of joint replacement have been pub-
lished elsewhere (Johnson et al., 2014). Within the
exploration of trial participation, interviews exam-
ined participants’ initial impressions of the trial;
knowledge and expectations of the trial (including
aims, trial arms, clinical equipoise, randomization,
blinding and data collection); decision-making re-
garding trial participation and experience and
acceptability of the trial (see Box 1). Analyses
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proceeded in parallel to data collection and contin-
ued until data saturation was reached such that no
new themes were arising from the data (Sandelowski,
1995). Patient interviews were conducted in par-
ticipants’ own homes by EJ between April 2010 and
January 2011. HCP interviews were undertaken in a
private ofﬁce on hospital premises by EJ (n = 13) and
JH (n = 2) between March 2011 and June 2012.
Data analysis
Interviews were audio-recorded, fully transcribed,
anonymized, checked for accuracy and imported into
a qualitative software package to aid data analy-
sis. Thematic analysis (Braun and Clarke, 2006) was
used to scrutinize the data to identify and analyze
patterns across the dataset. Transcripts were ex-
amined on a line-by-line basis with codes assigned
to segments of the data and an initial coding frame
developed. An inductive approach to coding was used
to identify participants’ perceptions of their expe-
riences. This generated an initial coding frame-
work which was added to and reﬁned as new data
were gathered. Codes were gradually built into
broader categories through comparison across tran-
scripts and higher-level recurring themes were de-
veloped. EJ undertook the initial systematic coding
of the transcripts. A subset of 4 patient and 8 HCP
transcripts was independently analyzed by JH and
RGH and any discrepancies discussed to contribute
to the generation and reﬁnement of codes and the-
matic categories to maximize rigor (Meyrick, 2006).
Results
Twenty six patients were invited to take part in the
interview and 24 agreed. These were 11 men and 13
women, aged 26–92 years (mean 65 years), 14 were
undergoing THR and 10 were undergoing TKR, 23 were
of white British ethnicity. Interviews lasting between
45 and 120 minutes were conducted two to four
weeks after surgery. Fifteen HCPs were approached
and all agreed to take part. These were 4 men and
11 women, aged 28–56 years (mean 44 years), com-
prising 3 pre-operative clinic nursing staff, 4 ortho-
paedic surgeons and 2 consultant anesthetists, 4 ward
nurses and 2 ward managers. Interviews with HCPs
lasted between 19 and 40 minutes.
Analysis led to the development of key themes that
relate to views and experiences of the APEX trials.
Themes provide information about patients’ ratio-
nale for taking part, their experiences of participa-
tion and HCPs’ views and experiences of trial
involvement. All initials refer to pseudonyms.
Patients’ reasons for RCT participation:
beneﬁting others
Patients said that they wanted to participate in an
RCT that had the potential to impact on other pa-
tients and to the advancement of knowledge. This
‘altruism’ was a prominent feature in the majority
of the patients’ accounts. Patients described the
value of the research on future patients in the
context of commitment and belief in the value of re-
search. A desire to help future patients was seen as
part of a wider system of reciprocal ‘social ex-
change’ that included reﬂection on the past as well
as the future: patients expressed gratitude to
unknown members of previous generations who had
participated in research that had contributed to im-
provements in medical care that they were cur-
rently receiving.
Well I just thought that anything that might help
people in the future. You know if people don’t do
things like that [then] improvements might take
place but probably a lot more slowly. I think that
it’s a good thing to do for the beneﬁt of people who
Box 1
Interview schedule
• Initial impressions: How did you ﬁrst hear about the APEX study? First impressions?
• Understanding: Study aims, trial arms, randomization, blinding, equipoise, what taking part would
involve, data collection, follow up period.
• Decision making: Why take part?
• Knowledge and expectations: Participation in research, trial arm (active, control), surgery
• Experience of trial participation/involvement: Acceptability, what worked well and improvements
• Data collection: Acceptability, timing
• Information and support: What worked well and improvements
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are having operations in the future really that’s why.
Mrs B, THR, age 65.
I feel if I can help other people from my experi-
ences then all well and good. That’s what it’s about
so as I say how are they gonna learn if you can’t learn
from other people. Mr I, TKR, age 51.
My attitude to that [trial involvement] is things they
know now somebody has done that in the past so if
they learn more it’s going to be valuable to people
in the future. I’m all for that . . . Years ago they used
to cut peoples legs off with saws, they’ve moved
on quite a bit from that haven’t they. Mrs Q, THR
age 75.
If I can help somebody else because somebody had
probably done something before me that could help
me. Mrs P, TKR, age 72.
Potential beneﬁts to patients
Although altruistic reasons for RCT participation were
common, patients frequently also said that they had
considered the possibility that participation might
confer physical beneﬁts to them in the shape of ad-
ditional pain relief. Patients described the poten-
tial beneﬁt of receiving more anesthetic if they had
been randomized to the intervention arm of APEX
while also demonstrating a good understanding of the
process of randomization and blinding.
When she [recruitment nurse] said they would inject
into the scar before they send me up I thought ‘oh
lovely a bit more pain, less pain’, but I don’t know
whether I had it done so I suppose it is in my mind.
I might have had it I don’t know. Mrs P, TKR age 76.
As well as possible physical beneﬁts of RCT par-
ticipation, patients described a range of potential
psychological beneﬁts. Some patients felt they might
beneﬁt from the research team monitoring their
health, for example: ‘somebody else is looking from
another corner at me’. Patients also thought that
completion of the questionnaires provided an alter-
native way to express, and thereby better under-
stand, their pain and outcomes. The daily 100 mm
pain visual analogue scale (VAS) pain scores that pa-
tients were asked to complete on days 1–3 post-
operative while in hospital helped quantify the
patients’ pain experience and learn more about their
recovery from surgery. In addition patients re-
ported a satisfaction and curiosity from contribut-
ing to research and were keen to know the results
of the RCT, including the arm that they were allo-
cated to, which was information that they would
receive after RCT completion.
I think for a certain degree that I had some skepti-
cism to a degree in my own mind that if there is a,
what if it went wrong, somebody else is looking from
another corner at me, it may help to decipher why,
when, where, what how it went wrong. Mr M, THR
age 50.
Oh my pain going down? [comparison of pain scores
completed in daily in-patient questionnaire] Yes
because you don’t think do you. You think every-
day ‘oh it is the same, oh I wish it would hurry up
oh it is still there’. But it wasn’t you could tell and
like when I get up in the morning and I would go to
the toilet, have my wash and come back in and then
I would sit and ﬁll it [in-patient questionnaire] and
I would think ‘oh it is a lot better today’. Mrs P, TKR
age 76.
I know I’ve been told it’s an opportunity to know
[about allocation within the trial] in a year’s time
if I’m interested and yes I would be interested. Mrs
O, THR age 52.
Yes, I suppose it’s [allocation within the trial] some-
thing to look forward to as well, to ﬁnd out yay or
nay. If it’s no well I don’t see that, at this particu-
lar moment I am healing quite well and getting going
in the right direction. Whether it would have made
any difference if I had had it or not I don’t know,
you know what chemical is it by comparison to
normal anesthetic, is it a super duper special, I don’t
know. So there are a lot of questions that I could
ask and would like to ask whether I’ve had it [the
intervention] or not, and what about the person who
has had it if I haven’t, how is he, or she, you know
by comparison to me. Mr M, THR age 50.
Patients’ perceived beneﬁts and costs of
trial participation
For the majority of patients RCT participation was
conditional on considering the perceived costs as-
sociated with the trial. Patients considered poten-
tial costs and beneﬁts of APEX participation and were
motivated to take part if they saw few negative con-
sequences to being randomized to either of the trial
arms. They considered that APEX participation con-
ferred minimal risk as patients in either trial arm
would receive standard anesthetic care while those
in the intervention arm would receive additional
treatment. Patients viewed both arms as accept-
able and did not feel like they would be ‘losing out
on anything’ if they were randomized to receive stan-
dard anesthetic care only. Patients understood that
APEX was a phase 3 trial of an anesthetic already rou-
tinely administered. This contributed to them viewing
trial participation as ‘low risk’ in comparison to a
phase 1 trial of a new drug which some said that they
would be reluctant to participate in. Additionally,
the majority of patients did not see the data
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collection requirements of APEX as burdensome.
Rather they viewed the data collection methods and
length of follow-up to be clear and acceptable. Many
stated that trial participation ‘gave them some-
thing to do’ while recovering from surgery and that
they had sufﬁcient time available to complete ques-
tionnaires. However, a minority of patients did say
they struggled with the length of some of the
questionnaires.
I thought well it’s not as though it’s going to be a
new drug what you’re testing . . . it’s only going to
be anesthetic but it’s only going to be a trial if it
works or it didn’t work. I mean it’s not as though
I’m going to lose anything if it doesn’t work. I
thought if it does work then I’ve gained a lot so it’s
not as though it’s going to be a new drug you’re
trying out. Mrs L, TKR age 46.
I thought well I’m retired, I’ve got time. It’s not as
though it’s going to be difﬁcult to ﬁt it [question-
naire] in and so you know, I’ve never thought ‘oh why
did I do that?’ Mrs B, THR age 65.
Yeah, I thought, ‘Well, somebody got to do it’, I
mean, all these things take time, and someone’s got
to do it, and I thought, ‘Well, I don’t mind, I won’t
be doing anything when I come home’. (Laughs).
Yeah, it’d be an interest anyway. Mrs E, THR age 79.
It [questionnaire] was hard work because there were
so many pages. Mrs B, THR age 65.
Healthcare professionals’ views of
RCT involvement
HCPs were happy to be involved in an RCT that was
understood to be an acceptable intervention and rel-
evant to the patient experience. HCPs saw pain re-
duction after surgery to be central to their
professional practice.
I think it’s [APEX trial] really valuable because the
more you can help people with pain, you know, it’s
really – I think that’s one thing that the patients are
frightened of, isn’t it, when they have surgery with
anybody? I would be . . .. So, you know, the ad-
vances in pain relief and making sure they’re rela-
tively pain-free, has got to be good. S8, Senior Nurse,
female.
That [the aims of the trial] rolls into what we’re
doing as well, to what you’re doing, and every-
thing is just contributing towards trying to keep the
patient pain-free for longer, and to get them
more mobile, and to get them out back into their
own home, which is good. S9, Trainee Nurse Prac-
titioner, female.
I thought that it was a good idea to give a little local
anesthetic, you know, so the patient, they’re more
comfortable when they wake up and the body gets
time to acclimatize, so to speak, to the pain, rather
than they wake up in serious pain. S10, Surgeon,
male.
Impact of RCT involvement
HCPs considered the potential impact of their in-
volvement in the delivery of APEX. Some did report
initial concerns including the possibility that their pro-
fessional conduct would be under scrutiny, an in-
crease in their workload and the logistics of recruiting
patients in a busy clinic. These concerns were alle-
viated once they learnt more about APEX, with many
commenting that they appreciated that it had been
designed to have minimal impact on, and to be nor-
malized into, their routine clinical practice.
It was a little bit worrying and we’d think, ‘oh gosh,
you know, we’re all being watched.’ (laughs) You
know, because you do think, oh research, are people
going to be coming in, and are they going to be asking
lots of questions? And I suppose sometimes there is
a fear there of thinking, ‘ohmy gosh, you know, what
is going to be expected?’ S2, Ward Nurse, female.
No I have no problem, I mean it’s a great opportu-
nity to contribute to research . . . So there’s not
much that we have to do there. OK, we had to just
do a standardized anesthetic and ﬁll in the form,
so I think you didn’t ask for too much. S14, Consul-
tant Anesthetist, female.
Well it’s just like part of what happens now. S7, Pre-
op Clinic Manager, female.
I thought it was going to be OK because essentially
it was using the same anesthetic that we were
already using for the knee, um for our primary knee
replacements. So I didn’t think it would have much
impact on what I did, in terms of the anesthetic, so
I was quite happy to go along with it. S12, Consul-
tant Anesthetist, female.
HCPs noted that the APEX research nurses played
a central support role in the smooth running of the
RCT. The research nurses were a visual reminder of
APEX and their daily presence allowed for opportu-
nities to clarify procedural details and reduce any
burden of the RCT on HCPs, which was appreciated
and welcomed.
Seeing someone every day is good. You know they
[research nurses] are going to come up, if there’s
any issues. Um. I suppose because I know [Ortho-
paedic surgeon] quite well that if I had any prob-
lems then I could always, you know. He’s very
approachable. As are all the team so I could easily.
So I think that’s worked well that they’re very
visible. S5, Ward Manager, female.
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If we’re not sure about it [APEX trial], we do ask,
you know. We’ve asked the APEX nurses, you know,
if we felt we weren’t sure on anything we could still
go up and ask them things, and that was really good.
S2, Ward Nurse, female.
We haven’t really asked for as much help as they [re-
search nurses] have offered. They have been here
and given us a lot of information and they have again
been offering staff any support they can possibly
think of and um you know whether it was to do with
ﬁlling out the forms or where we put the forms after
we have completed them. You know what sort of
support we need to give the patients. So yes they’ve
been excellent really. S6, Ward Manager, female.
RCT visibility
An initial challenge for trial conduct was the need
to inform a large clinical team (pre-assessment, sur-
gical and ward staff) about the presence of APEX and
the requirements it would place on them. HCPs wel-
comed the diverse methods used initially to notify
them about APEX and subsequently about its prog-
ress. APEX posters were displayed in hospital corri-
dors and these were thought to be an effective means
to inform patients and remind HCPs about APEX. For
HCPs, the availability of the APEX protocol in clini-
cal workplaces helped them to implement the APEX
trials. Increasing the visibility of protocols as APEX
progressed was described as of value. Some ward-
based HCPs reﬂected that receiving information per-
sonally would have been more helpful to them than
the generic information provided.
Alongside information within the hospital, APEX
was publicly launched with a local media presence
in newspapers and television. Pre-operative assess-
ment clinic staff, where patients were recruited,
commented on the positive impact of the media cam-
paign, with patients more willing to wait longer to
speak to the recruiting research nurses.
We were told at our staff meeting, which was really
good. . . . By [manager name]. But also the posters
around the place as well, you know, informing the
patients and, you know, just highlighting it again to
the staff. S9, Trainee Nurse Practitioner, female.
I ﬁrst heard about it from [Surgeon], you know, by
just discussing it, you know, and then we had a few
talks in the department about it. [Anesthetist], who
is on your steering committee and a co-applicant,
would send emails around about what is required,
so it was quite well advertised. S14, Consultant Anes-
thetist, female.
We had copies of the protocol in the anesthetic
room. I suppose at the beginning the protocols were
less obvious. So recently, probably in the last, I don’t
know when they were done, but they were lami-
nated and put up and so they were deﬁnitely there
telling you exactly what to do at each stage. S12,
Consultant Anesthetist, female.
I just think sometimes obviously, instead of just
saying, ‘Oh everything’s in a folder’, because we’ve
got so many policies and things like that to read, it
would be quite nice if we had sort of like a leaﬂet,
you know, a letter that we could open. And I think
more people would tend to read over that than be
able to make the time to go and see another folder.
S2, Ward Nurse, female.
Because there was something, was it on the televi-
sion or in the newspaper? . . . Yeah and after that
happened, more patients asked, which I think it
made the whole thing easier. Because patients were
asking, we could ask them to wait a bit
more . . .. Whereas when they didn’t know about it
they were reluctant to wait. S7, Pre-op Clinic
Manager, female.
Discussion
The study sought to investigate patients’ and HCPs’
views of RCT involvement. Both parties reported they
were initially interested in APEX as they saw it as a
crucial area of research and of great relevance to pa-
tients’ experiences of surgery. Findings demon-
strate the importance of addressing a question of
substantial interest, relevance and value to both HCPs
and patients. This demonstrates the need to provide
clear information for both patients and HCPs to
explain the rationale and signiﬁcance of an RCT.
Patients were motivated to participate in APEX by
a combination of altruism, perceived beneﬁts (or
absence of concerns) and consideration of the trial
requirements. APEX was seen to present minimum
burden: patients saw the possibility of randomiza-
tion to either trial arms and the requirements of data
collection as acceptable. Aminority of patients stated
purely altruistic reasons for trial participation, with
many additionally reporting a variety of potential psy-
chological and physical personal beneﬁts. Per-
ceived beneﬁts included possible reduced pain, active
engagement in their health and intellectual curios-
ity. Concurrently, patients demonstrated sound un-
derstanding of the APEX trial design and the processes
of randomization and blinding by acknowledging that
they may not personally beneﬁt from the RCT. Our
ﬁndings concur with ﬁndings from other patient
groups which suggest that individuals are rarely mo-
tivated to take part in research based solely on the
altruistic consideration of helping others (Carroll
et al., 2012; Locock and Smith, 2011; McCann et al.,
2010; Simmonds et al., 2013). Rather, individuals
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are more likely to be motivated by ‘conditional
altruism’ (McCann et al., 2010) where individuals may
additionally perceive some personal beneﬁt (and no
signiﬁcant disadvantage) in taking part in research
(Carroll et al., 2012; Locock and Smith, 2011; McCann
et al., 2010; Simmonds et al., 2013).
It is therefore important to understand that mo-
tivations for trial participation are multifaceted and
interrelated (Hallowell et al., 2010; Locock and
Smith, 2011) and should be considered in the context
of both personal and social beneﬁts (McCann et al.,
2010). Mentioning altruism during recruitment as a
means of reminding patients of the trial purpose has
been advocated (Joffe, 2006) but this needs to be
done with an awareness that personal consider-
ation of beneﬁts also plays an important role in RCT
participation decisions. Our ﬁndings demonstrate the
importance of employing a patient-centered ap-
proach during recruitment and allowing time to
provide clear information about each trial arm and
the requirements that participation entails, as pre-
viously suggested (Morris and Bàlmer, 2006). This
should be done alongside exposure and discussion of
any misunderstandings about the RCT as well as
addressing expectations that might not be met
(Sikweyiya and Jewkes, 2013; Wasan et al., 2009).
Peer-review has already been used to assist recruit-
ment staff to develop their communication skills
(Mann et al., 2013) and can ensure recruitment in-
terviews are personalized, rather than an ‘one size
ﬁts all’ scripted recruitment method.
HCPs also weighed up the perceived beneﬁts and
costs associated with APEX involvement. Satisfac-
tory trial burden was accomplished by employing re-
search nurses so APEX had minimal impact on HCPs’
daily clinical practice. Research nurses were also
valuable for clarifying procedural details to ensure
protocol adherence. Our study demonstrates that
RCTs have the potential to be successfully normal-
ized into clinical practice. The data reveal the need
for minimal personal burden of RCT involvement for
all involved. This has been previously suggested as
an important factor in increasing satisfaction with
trial personnel and trial procedures which can have
a positive impact on retention rates (Jerosch-Herold
et al., 2011). It is therefore vital that RCTs are care-
fully planned and adequately resourced to avoid
making unnecessary demands which have previ-
ously been demonstrated to affect the recruitment
of both patients and HCPs (Ellis, 2000; Mason et al.,
2007). It is also critical to ensure that data collec-
tion requirements and follow-up duration are clini-
cally meaningful and appropriate without placing
onerous burden on patients and HCPs to overcome
the operational challenges of conducting RCTs in or-
thopaedic surgery (Losina et al., 2012).
Factors that inﬂuence the validity and
generalizability of results from RCTs include non-
adherence to the study protocol and completeness
of follow-up data (Overall et al., 1998). Adherence
to protocol is critical to ensure that the outcome of
the RCT is attributed to the corresponding treat-
ment arm. RCTs are often conducted in busy clini-
cal environments, over long periods of time and with
RCT patients interspersed between routine pa-
tients (Swiontkowski and Agel, 2012). It is there-
fore easy for HCPs to lose focus on RCTs taking place
in their clinics. Our data highlight the importance of
initial and ongoing visibility of the RCT. The ﬁnd-
ings from our study indicate that HCPs value the op-
portunity to discuss the study and its protocol with
research staff and that this complements written ma-
terial. This can be bolstered by ongoing availability
of research staff as an RCT progresses. Ensuring com-
pleteness of follow-up data when data are patient-
reported may hinge on patients’ belief in the value
of the data and of their participation (Jerosch-Herold
et al., 2011; Swiontkowski and Agel, 2012). In the
APEX trials patients described the value of trial par-
ticipation to themselves, to others and to society as
a whole. Patients also saw questionnaire comple-
tion as potentially beneﬁcial to them and only some
found the questionnaire length a challenge. A con-
sideration for future orthopaedic RCTs might be the
fact that completion of questionnaires may be seen
as beneﬁcial in its own right.
This study aimed to undertake an in-depth inves-
tigation of orthopaedic trial participation. The data
analysis was robust as a proportion of interview tran-
scripts were coded independently and themes dis-
cussed within the research team. A diverse range of
patients in terms of age and gender and HCPs in terms
of role were interviewed and analysis showed com-
monality in views and experiences. This has enabled
a comprehensive insight into RCT involvement from
multiple perspectives and ﬁndings may be appli-
cable to other RCTs. However, the data were derived
only from patients who agreed to participate in APEX
who may hold particular views about research that
are not generalizable to the wider population. In ad-
dition, the sample was drawn from a single site RCT
and most patients were of white British ethnicity,
so it is possible that the views and experiences of pa-
tients from other locations or of different ethnicities
would differ. However, the APEX trial was con-
ducted at one of the largest orthopaedic centers in
the UK which serves patients from a wide geographi-
cal area.
The study demonstrates that patients and HCPs
value contributing to an RCT viewed as relevant and
of value. When patients decide to take part in an RCT
they also weigh up perceived beneﬁts and demands
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of participation alongside altruistic considerations,
although altruism is often not the primary motivat-
ing factor. It is therefore important to design and ad-
equately resource RCTs so that they impose minimum
burden on patients and HCPs.
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